Tumor induction and tissue atrophy in mice lacking E2F-1

L Yamasaki1, T Jacks, R Bronson

  • 1Massachusetts General Hospital Cancer Center, Charlestown 02129, USA.

Cell
|May 17, 1996
PubMed

Insights

Loss of E2F-1, a protein regulating gene expression, surprisingly leads to tumor development in mice. This indicates E2F-1 acts as a crucial tumor suppressor, contrary to previous in vitro findings.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • The retinoblastoma tumor suppressor protein (pRB) represses transcription by binding to E2F factors.
  • Mutations in pRB and its regulators are frequent in human cancers.
  • The in vivo function of the pRB-E2F pathway remains largely uncharacterized.

Purpose of the Study:

  • To investigate the in vivo function of E2F-1 and pRB/E2F-1 complexes.
  • To determine the physiological role of E2F-1 in mammalian development and tumorigenesis.

Main Methods:

  • Generation of mice homozygous for a nonfunctional E2F-1 allele.
  • Phenotypic analysis of E2F-1 deficient mice, including reproductive and developmental assessments.
  • Tumor spectrum analysis in E2F-1 knockout mice.

Main Results:

  • E2F-1 deficient mice are viable and fertile but exhibit testicular atrophy and exocrine gland dysplasia.
  • Mice lacking E2F-1 develop a wide and unexpected range of tumors.
  • In vitro studies suggested E2F-1 is oncogenic, but in vivo data contradicts this.

Conclusions:

  • E2F-1 plays a critical role in preventing tumor formation in vivo.
  • Loss of E2F-1 function acts as a tumor suppressor, leading to tumorigenesis.
  • The physiological role of E2F-1 is complex, with distinct functions in vitro and in vivo.